Phase II Study of Irinotecan/Capecitabine in Patients With Antracycline/Taxane Pretreated MBC
Clinical trial NCT00532714 · COMPLETED
Trial details
- NCT number
- NCT00532714
- Sponsor
- National Cancer Center, Korea
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2008-04-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.